Lamivudine treatment in maternally transmitted chronic hepatitis B virus infection patients
โ Scribed by Yen-Hsuan Ni; Fu-Chen Huang; Tzee-Chung Wu; Man-Shan Kong; Yung-Ming Jeng; Pei-Jer Chen; Daw-Jen Tsuei; Huey-Ling Chen; Hong-Yuan Hsu; Mei-Hwei Chang
- Book ID
- 108971026
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 102 KB
- Volume
- 47
- Category
- Article
- ISSN
- 1328-8067
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
It is well established that during lamivudine treatment, mutations emerge within the polymerase gene but there is little information about the selection of other mutations in the whole hepatitis B virus (HBV) genome. The aim of this study was to investigate whether mutations outside this region are
Recent advances in our understanding of the replicative mechanism of HBV, and the development of potent nucleoside analogues as clinically effective inhibitors of the HIV reverse transcriptase or herpesvirus polymerases has opened a new era in the treatment of chronic HBV infection. Single agent the